The endocannabinoid system of the brain - From neurobiology to clinical relevance;Das endocannabinoide System des Gehirns - Von der Neurobiologie zur klinischen Relevanz

Neuroforum

Volumn 14, Issue 4, 2008, Pages 256-267

  Wegener, Nico ^a   Schneider, Miriam ^b   Koch, Michael ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cannabis; CB1 receptor; Endocannabinoid; Puberty; Schizophrenia; THC; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CP 55 940; DRONABINOL; ENDOCANNABINOID; RIMONABANT; UNCLASSIFIED DRUG; WIN 55 212 2;

ARTICLE; COGNITION; HUMAN; MOTOR SYSTEM; NEUROMODULATION; PROTEIN EXPRESSION; RECEPTOR BINDING; SENSORY SYSTEM;

EID: 57549098578     PISSN: 09470875     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ameri, A. (1999): The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348.
2. Arseneault, L., Cannon, M., Witton, J. und Murray, R.M. (2004): Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110-117.
3. Breivogel, C.S., Sim, L.J. und Childers, S.R. (1997): Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther 282: 1632-1642.
4. Caspi, A., Moffitt, T.E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R. und Craig, I.W. (2005): Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene environment interaction. Biol Psychiatry 57: 1117-1127.
5. Chaperon, F. und Thiebot, M.H. (1999): Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13: 243-281.
6. Di Matzo, V., Breivogel, C.S., Tao, Q., Bridgen, D.T., Razdan, R.K., Zimmer, A.M., Zimmer, A. und Martin, B.R. (2000): Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 75: 2434-2444.
7. Elphick, M.R. und Egertova, M. (2001): The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 356: 381-408.
8. EMCDDA (European monitoring cen tre for drugs and drug addiction). The state of the drugs problem in europe (2007).
9. Fernandez-Ruiz, J.J., Berrendero, F., Hernandez, M.L., Romero, J. und Ramos, J.A. (1999): Role of endocannabinoids in brain development. Life Sci 65: 725-736.
10. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., De Costa, B.R. und Rice, K.C. (1991): Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563-583.
11. Koch, M. (1999): The neurobiology of startle. Prog Neurobiol 59: 107-128.
12. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. und Parmentier, M. (1999): Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404.
13. Lupica, C.R., Riegel, A.C. und Hoffman, A.F. (2004): Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 143: 227-234.
14. Piomelli, D. (2003): The molecular logic of endocannabinoid signalling. Aust N Z J Psychiatry 40: 105-113.
15. Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A.L. und Gessa, G.L. (2004): Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry 56: 86-94.
16. Rodriguez de Fonseca, F., Ramos, J.A., Bonnin, A. Fernandez-Ruiz, J.J. (1993): Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 4: 135-138.
17. Schneider, M. und Koch, M. (2003): Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28: 1760-1769.
18. Schneider, M. (2008): Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addiction Biol 13: 253-263.
19. Tanda, G., Loddo, P. und Di Chiara, G. (1999): Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol. Eur J Pharmacol 376: 23-26.
20. Watson, S.J., Benson, J.A. Jr und Joy, J.E. (2000): Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psychiatry 57: 547-552.
21. Wegener, N., Kuhnert, S., Thüns, A., Roese, R. und Koch, M. (2008): Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion, and spatial memory in rats. Psychopharmacology 198: 375-385.